In the version of this article initially published, representative HER2-stained histology images in Extended Data Fig. 3c, Fig. 4f and Extended Data Fig. 6g were incorrectly assembled. Extended Data Fig. 3c contained two images from the same CTC Brx-82-derived HER2+ tumour; these have been replaced with correct images from the respective CTC Brx-82-derived HER2− and HER2+ xenografts. In Fig. 4f, paclitaxel-treated and post-treatment recovery images were mistakenly sourced from untreated CTC Brx-142-derived tumors; these have been replaced with correct treated (T) and post-recovery (R) images. Extended Data Fig. 6g contained an incorrect post-recovery image. Due to the age of the article, the figures cannot be updated directly. Revised images are available as Supplementary Information accompanying this amendment. This notice serves to correct the article.
Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells
Why This Matters
This correction highlights the importance of accuracy in scientific imaging, which is crucial for reliable research and clinical insights into breast cancer. Ensuring precise data representation helps advance targeted therapies and improves patient outcomes. The update underscores the ongoing commitment to scientific integrity in the tech and healthcare sectors.
Key Takeaways
- Accurate imaging is vital for reliable cancer research data.
- Corrections ensure the integrity of scientific publications.
- Precise data supports the development of targeted breast cancer therapies.
Get alerts for these topics